Hydroxocobalamin and X-ray limb abnormal - a phase IV clinical study of FDA data


We study 3,542 people who take Hydroxocobalamin or have X-ray limb abnormal. No report of X-ray limb abnormal is found in people who take Hydroxocobalamin.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 01, 2022

No report is found.

What is Hydroxocobalamin?

Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 3,424 Hydroxocobalamin users for its effectiveness, alternative drugs and more.

What is X-ray Limb Abnormal?

X-ray limb abnormal is found to be associated with 257 drugs and 110 conditions by eHealthMe.

Do you take Hydroxocobalamin and have X-ray limb abnormal?

Check whether X-ray limb abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was X-ray limb abnormal and when was it recovered:

Expand to all the drugs that have ingredients of hydroxocobalamin:

Alternative drugs to, pros and cons of Hydroxocobalamin:

X-ray limb abnormal treatments and more:

COVID vaccines that are related to X-ray limb abnormal:

All the drugs that are associated with X-ray limb abnormal:

All the conditions that are associated with X-ray limb abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on hydroxocobalamin (the active ingredients of Hydroxocobalamin) and Hydroxocobalamin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: